CN104784657A - Application of traditional Chinese veterinary medicine compound preparation for preparing medicine for treating chicken colibacillosis - Google Patents
Application of traditional Chinese veterinary medicine compound preparation for preparing medicine for treating chicken colibacillosis Download PDFInfo
- Publication number
- CN104784657A CN104784657A CN201510124327.4A CN201510124327A CN104784657A CN 104784657 A CN104784657 A CN 104784657A CN 201510124327 A CN201510124327 A CN 201510124327A CN 104784657 A CN104784657 A CN 104784657A
- Authority
- CN
- China
- Prior art keywords
- chicken
- test
- compound preparation
- loose
- colibacillosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 204
- 239000003814 drug Substances 0.000 title claims abstract description 90
- 238000002360 preparation method Methods 0.000 title claims abstract description 68
- 150000001875 compounds Chemical class 0.000 title claims abstract description 29
- 241000746375 Andrographis Species 0.000 claims abstract description 58
- 239000000843 powder Substances 0.000 claims abstract description 30
- 238000005516 engineering process Methods 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 206010012735 Diarrhoea Diseases 0.000 claims description 45
- 229940079593 drug Drugs 0.000 claims description 41
- 241000411851 herbal medicine Species 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 20
- 241000699670 Mus sp. Species 0.000 claims description 16
- 230000000968 intestinal effect Effects 0.000 claims description 12
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 230000001629 suppression Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 43
- 239000000463 material Substances 0.000 abstract description 22
- 230000007480 spreading Effects 0.000 abstract description 5
- 238000003892 spreading Methods 0.000 abstract description 5
- 244000144977 poultry Species 0.000 abstract description 3
- 239000011362 coarse particle Substances 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 206
- 235000013330 chicken meat Nutrition 0.000 description 181
- 240000002853 Nelumbo nucifera Species 0.000 description 107
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 107
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 107
- 239000002304 perfume Substances 0.000 description 103
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- 238000000034 method Methods 0.000 description 45
- 235000019640 taste Nutrition 0.000 description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 40
- 239000000243 solution Substances 0.000 description 34
- 201000010099 disease Diseases 0.000 description 32
- 241000588724 Escherichia coli Species 0.000 description 29
- 230000008569 process Effects 0.000 description 26
- 210000000952 spleen Anatomy 0.000 description 25
- 208000024891 symptom Diseases 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000007788 liquid Substances 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 231100000614 poison Toxicity 0.000 description 18
- 239000003440 toxic substance Substances 0.000 description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- 235000013601 eggs Nutrition 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 15
- 208000007893 Salpingitis Diseases 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 13
- 239000012567 medical material Substances 0.000 description 13
- 235000014590 basal diet Nutrition 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000007689 inspection Methods 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 235000008216 herbs Nutrition 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 230000036285 pathological change Effects 0.000 description 9
- 231100000915 pathological change Toxicity 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 230000004087 circulation Effects 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000013558 reference substance Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- HRYLQFBHBWLLLL-UHFFFAOYSA-N (+)-costunolide Natural products C1CC(C)=CCCC(C)=CC2OC(=O)C(=C)C21 HRYLQFBHBWLLLL-UHFFFAOYSA-N 0.000 description 7
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 description 7
- CUGKULNFZMNVQI-UHFFFAOYSA-N Costunolid I Natural products CC1=CCC=C(/C)CCC2C(C1)OC(=O)C2=C CUGKULNFZMNVQI-UHFFFAOYSA-N 0.000 description 7
- WKSUCCVMYJRMFR-UHFFFAOYSA-N Dehydrocostus lactone Natural products C12OC(=O)C(=C)C2CCC(=C)C2(C)C1(C)C(=C)CC2 WKSUCCVMYJRMFR-UHFFFAOYSA-N 0.000 description 7
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 description 7
- 238000010171 animal model Methods 0.000 description 7
- 230000001142 anti-diarrhea Effects 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- HRYLQFBHBWLLLL-AHNJNIBGSA-N costunolide Chemical compound C1CC(/C)=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]21 HRYLQFBHBWLLLL-AHNJNIBGSA-N 0.000 description 7
- MMTZAJNKISZWFG-UHFFFAOYSA-N costunolide Natural products CC1CCC2C(CC(=C/C=C1)C)OC(=O)C2=C MMTZAJNKISZWFG-UHFFFAOYSA-N 0.000 description 7
- NETSQGRTUNRXEO-XUXIUFHCSA-N dehydrocostus lactone Chemical compound C([C@H]1C(=C)C(=O)O[C@@H]11)CC(=C)[C@H]2[C@@H]1C(=C)CC2 NETSQGRTUNRXEO-XUXIUFHCSA-N 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 210000003101 oviduct Anatomy 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 235000013312 flour Nutrition 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 229960002983 loperamide hydrochloride Drugs 0.000 description 5
- PGYPOBZJRVSMDS-UHFFFAOYSA-N loperamide hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 PGYPOBZJRVSMDS-UHFFFAOYSA-N 0.000 description 5
- 206010025482 malaise Diseases 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000010172 mouse model Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 206010034674 peritonitis Diseases 0.000 description 5
- 238000011020 pilot scale process Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010020565 Hyperaemia Diseases 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- -1 dehydrorographolide Chemical compound 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 210000003516 pericardium Anatomy 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010008631 Cholera Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 238000009361 aviculture Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 244000144992 flock Species 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000006916 nutrient agar Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 206010034754 petechiae Diseases 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000012797 qualification Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000238367 Mya arenaria Species 0.000 description 2
- 206010071301 Perihepatitis Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000006153 eosin methylene blue Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000008738 huangbai Substances 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000008494 pericarditis Diseases 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- XPNGNIFUDRPBFJ-UHFFFAOYSA-N (2-methylphenyl)methanol Chemical compound CC1=CC=CC=C1CO XPNGNIFUDRPBFJ-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010004663 Biliary colic Diseases 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 239000009413 Chuanxinlian Substances 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 241000045500 Diseae Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010061126 Escherichia infection Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001237160 Kallima inachus Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- VXDSLUMUNWTSDB-UHFFFAOYSA-N acetic acid;chloroform;methanol Chemical compound OC.CC(O)=O.ClC(Cl)Cl VXDSLUMUNWTSDB-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- MSQDVGOEBXMPRF-UHFFFAOYSA-N cyclohexane;propan-2-one Chemical compound CC(C)=O.C1CCCCC1 MSQDVGOEBXMPRF-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000036750 egg laying performance Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000020612 escherichia coli infection Diseases 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an application of a traditional Chinese veterinary medicine compound preparation for preparing a medicine for treating chicken colibacillosis, and particularly relates to an application of a traditional Chinese veterinary medicine compound preparation for preparing a medicine for treating chicken colibacillosis in subtropical climate regions such as Southern China. The traditional Chinese veterinary medicine compound preparation comprises the following components by percent: 5-55% of common andrographis herb, 10-65% of rhizoma atractylodis, 5-55% of radix aucklandiae, 5-55% of cortex magnoliae officinalis and 10-65% of rhizoma zingiberis. The traditional Chinese veterinary medicine compound preparation is powder. A preparation technology comprises the steps that the five traditional Chinese medicinal materials are crushed into coarse particles respectively, are mixed according to a prescription ratio, are further pulverized, pass through a 30-mesh sieve, are placed in a V-shaped mixer for mixing for 30min, and then are subpackaged. The traditional Chinese veterinary medicine compound preparation particularly has a very good curative effect on the chicken colibacillosis in high-temperature, rainy and hot-humid regions, can effectively control spreading and diffusion of the chicken colibacillosis, is safe and small in side effect, is significant for poultry husbandry in the subtropical climate regions such as Southern China, and has better economic and social significance.
Description
Technical field
The invention belongs to herbal medicine technical field.More specifically, the application of a kind of herbal medicine compound preparation in the medicine of preparation treatment chicken colibacillosis is related to.
Background technology
In recent years, along with the development of aviculture, chicken colibacillosis extensively betides poultry-farm in all parts of the country, and becomes a primary study object in veterinary clinic diseases prevention and treatment already.Chicken colibacillosis is common clinical, frequently-occurring disease, by number of ways infected chicken, cause chicken multiple organ inflammation and can cause death, this sick rapid onset, infectiousness are strong, carrying out huge economic loss to cultivation industrial belt, is one of infectious disease of harm aquaculture.
Current most of raiser prevents and treats colibacillary thinking and is still medicine and controls, and this disease of clinical treatment is main based on antimicrobial drug, but has R-plasmid due to escherichia coli, easily produce drug resistance, reduction curative effect of medication, therefore clinical therapeutic efficacy is poor; Simultaneously due to a large amount of, the Use out of range of antimicrobial drug, cause drug residues a large amount of in Carnis Gallus domesticus and egg, carry out great hidden danger to food seat belt.In addition, due to the impact of the comprehensive extraneous factors such as weather, for different regions poultry-farm, obvious diversity is also also existed to the control of chicken colibacillosis.
South China, especially South China, based on subtropical monsoon climate, annual precipitation is 1400 ~ 2000 millimeters, high temperature and rainy, damp and hot, aquaculture is chicken farm especially, and chicken colibacillosis all can occur throughout the year, every year rainy, sultry, wet season is multiple, prevention effect is poor, easily recurs.
In this context, especially for the aviculture in the subtropical climate areas such as China south China, develop the herbal medicine new drug of safe and effective, that side effect is little treatment chicken colibacillosis, there is good economic implications and social meaning.
Summary of the invention
The technical problem to be solved in the present invention is the defect and the deficiency that overcome existing chicken colibacillosis medicine, a kind of application of herbal medicine compound preparation in preparation control chicken colibacillosis medicine for the treatment of chicken colibacillosis is provided, especially for the application in the subtropical climate areas such as China south China, spreading and spreading of this disease is controlled.
Above-mentioned purpose of the present invention is achieved through the following technical solutions:
Treat the application of herbal medicine compound preparation in the medicine of preparation treatment chicken colibacillosis for chicken colibacillosis, the application especially in the medicine of preparation treatment subtropical climate area chicken colibacillosis.
Preferably, described subtropical climate area refers to South China of China.
Above-mentioned herbal medicine compound preparation is made up of the component of following percentage composition: 5 ~ 55% Herba Andrographis, 10 ~ 65% Rhizoma Atractylodis, 5 ~ 55% Radix Aucklandiae, 5 ~ 55% Cortex Magnoliae Officinalis, 10 ~ 65 % Rhizoma Zingiberiss.
The dosage form of the herbal medicine compound preparation of described treatment chicken colibacillosis is powder, and preparation technology is as follows: after five kinds of Chinese crude drugs are broken into coarse granule respectively, mix in prescription ratio, further fine powder is broken, crosses 30 mesh sieves, puts in V-Mixer and mixes 30 minutes, subpackage.
Preferably, the herbal medicine compound preparation of above-mentioned treatment chicken colibacillosis is made up of the component of following percentage composition: 10 ~ 40% Herba Andrographis, 15 ~ 55% Rhizoma Atractylodis, 10 ~ 40% Radix Aucklandiae, 10 ~ 40% Cortex Magnoliae Officinalis, 15 ~ 55% Rhizoma Zingiberiss.
More preferably, the herbal medicine compound preparation of above-mentioned treatment chicken colibacillosis is made up of the component of following percentage composition: 10 ~ 25% Herba Andrographis, 20 ~ 35% Rhizoma Atractylodis, 10 ~ 25% Radix Aucklandiae, 1 ~ 25% Cortex Magnoliae Officinalis, 20 ~ 35% Rhizoma Zingiberiss.
Most preferably, the herbal medicine compound preparation of above-mentioned treatment chicken colibacillosis is made up of the component of following percentage composition: Herba Andrographis 16.7%, Rhizoma Atractylodis 25%, the Radix Aucklandiae 16.7%, Cortex Magnoliae Officinalis 16.6%, Rhizoma Zingiberis 25%.
The herbal medicine compound preparation of above-mentioned treatment chicken colibacillosis is preparing the application in the medicine for the treatment of chicken diarrhea also within protection scope of the present invention, and described chicken diarrhea is the diarrhoea caused by Oleum Ricini or Folium Sennae.
The herbal medicine compound preparation of above-mentioned treatment chicken colibacillosis is preparing the application in suppression chicken or mice Intestinal pushing function medicament also within protection scope of the present invention.
The pharmaceutical characteristic of each active component of the present invention is as follows:
Herba Andrographis: heat-clearing and toxic substances removing, removing heat from blood are subsided a swelling.Cure mainly the cardiovascular disease such as acute bacillary dysentery, gastroenteritis, upper respiratory tract infection, cold, fever and hypertension.Modern medicine study shows, Herba Andrographis has obvious inhibitory action to avian pasteurella multocida, S. pullonum, escherichia coli, staphylococcus aureus, bacillus pyocyaneus etc., also has antiinflammatory, antivirus action simultaneously.On modern clinic, also conventional CHUANXINLIAN ZHUSHEYE treats diarrhoeal diseases.
Rhizoma Atractylodis: expelling wind and cold, the spleen strengthening and damp drying.Cure mainly distension and fullness in the abdomen, the retention of dampness in middle-JIAO card such as to have loose bowels.Modern pharmacological research shows, Rhizoma Atractylodis all have obvious inhibitory action to staphylococcus aureus, tulase, dead leaf bacillus and bacillus pyocyaneus, and the mice that causes of the mouse small intestine diarrhoea that Oleum Ricini is caused and Folium Sennae too enteral diarrhea have obvious anti-diarrhea effect.In addition, Rhizoma Atractylodis also have inhibitory action in various degree to the multiple fungus such as trichophyton, trichophyton gypseum.
The Radix Aucklandiae: promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion.The treatment of the digestive tract disease such as treating gastric ulcer, biliary colic, diarrhoea is the common medicine for the treatment of gastrointestinal disease.Modern pharmacological research shows, the Radix Aucklandiae can reduce mouse small intestine diarrhoea and large enteral diarrhea number of times, also has weak inhibitory action to mice prepared Chinese ink gastrointestinal propulsion.
Cortex Magnoliae Officinalis: dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards are except full.Cure mainly humidity hysteresis damaging the spleen and stomach, the vomiting and diarrhoea of gastral cavity painful abdominal mass, stagnation of QI due to dyspepsia, abdominal distention constipation, phlegm retention breath with cough, have antiulcer and regulate the effect of digestive system.
Rhizoma Zingiberis: warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, dampness expectorant.Cure mainly enteritis, diarrhoea, vomiting etc.Modern pharmacological research shows, Rhizoma Zingiberis has the antibacterial Zuo ﹑ of the scorching Zuo ﹑ of analgesia Kang and improves the effects such as local blood circulation.
But, for the treatment of chicken colibacillosis in real life, not not merely apply the curative effect that can suppress colibacillary medicine just can to obtain, the integrated survey of the birds life habits such as chicken and physiological situation is also absolutely necessary, the effect that environmental factors is treated for chicken colibacillosis also has great impact, therefore composite for medicine, must consider the impact of environmental factors, just can reach optimum therapeutic effect.
The loose treatment being mainly used in chicken colibacillosis of lotus perfume of the present invention, especially for high temperature, rainy, damp-heat area, both selected Herba Andrographis heat-clearing and toxic substances removing, the dampness of bitter cold, compatibility Rhizoma Atractylodis are drying damp and strengthening spleen again; The Radix Aucklandiae, Cortex Magnoliae Officinalis circulation of qi promoting removing dampness, help with Rhizoma Zingiberis needle warming moxibustion with dehumidifying, and the property of his medicine bitter cold of assistant system is to protect gastric qi, and all medicines share, and play the merit of heat-clearing and toxic substances removing, spleen invigorating dehumidifying, antidiarrheal altogether.Because except turbid damp and antidiarrheal, except part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels turbid damp improves tunica mucosa tubae uterinae hyperemia, rotten to the corn thinning, play antiinflammatory bacteriostasis efficacy.
The prescription composition of this aspect is scientific and reasonable: Herba Andrographis heat-clearing and toxic substances removing, dampness removing and diarrhea-relieving are monarch drug, and Rhizoma Atractylodis the spleen strengthening and damp drying is ministerial drug, and the Radix Aucklandiae, Cortex Magnoliae Officinalis circulation of qi promoting removing dampness are adjuvant drug, and dehumidifying that Rhizoma Zingiberis is needle warming moxibustion is for making medicine.Common except damp and hot, adjust taste, antidiarrheal dysentery.In side, Herba Andrographis is bitter, cold.Return large intestine channel, heat clearing away large intestine detoxifies, removing heat from blood dampness-eliminating and dysentery-stopping.
Rhizoma Atractylodis: pungent, bitter, temperature.Return taste warp.
yE Tian shi"
linzheng Zhinan Yi" say: " and husband's epidemic disease is foul gas, ancients thus drink fragrance, adopt Herba Chlorophyti, to attack the gas of fragrance also, heavily wash also dirty." " Mingyi Bielu " record Rhizoma Atractylodis " swollen by edema due to wind pathogen knot between skin, except spasm in the epigastrium is full and cholera is told incessantly lower, warming the stomach rapid digestion of food is addicted to food for main headache, expectorant water." Compendium of Material Medica: " control damp-phlegm prolonged fluid-retention ... spleen wets dirty, turbid drop leukorrhagia, lingering diarrhea hemorrhoidal hamorrhage." the bitter temperature of Rhizoma Atractylodis, the power of dry taste turbid damp wins especially, the pungent perfume (or spice) of its gas, can invigorating the spleen and regulating the stomach, to help disease chicken food for taking a turn for the better, reduces diarrhoea number of times.
The Radix Aucklandiae, pungent, bitter, temperature.Return
taste, large intestine channel." medicineization justice " cloud: " Radix Aucklandiae, perfume can be ventilated, and closes the five internal organs, for adjusting all gas key medicines.Control the vexed belch of painful abdominal mass with this, edema abdominal distention, dysentery beriberi, all adjust the merit of stagnant loose gas.Therefore this product benefaction gastrointestinal stagnation of QI, intestinal stasis relieving pain relieving in tune, for the disease of weight after dysentery." " Japan hanako materia medica ": " and control all gas of trusted subordinate, antidiarrheal, cholera, dysentery, antiabortive, strengthening the spleen to promote digestion.Treat win bad, bladder cold type of pain, vomiting and regurgitation." " herbal classic ": " main pathogen, wards off malicious epidemic disease, Qiang Zhi, main pouring dew.”
Cortex Magnoliae Officinalis, bitter, pungent, temperature.Return spleen, stomach, large intestine channel." Mingyi Bielu ": " main warming middle-JIAO, QI invigorating, the expectorant therapeutic method to keep the adverse QI flowing downwards.Control cholera and stomachache, distension, cold in the stomach is inverse, and vomiting is more than in the heart, lets out dysentery, drenches dew.Except frightened, going or staying heat, only stuffy sensation with restlessness, thick the intestines and stomach." " book on Chinese herbal medicine just " cloud Cortex Magnoliae Officinalis can " temperature drop, falls apart stagnant, eliminating cold-damp dysentery." the bitter dry pungent row of this product, can dampness, again can circulation of qi promoting, benefaction gastrointestinal stagnation of QI distension." good recipe tested by collection " stops immediately watery diarrhea side, and " Shengji Zonglu " Cortex Magnoliae Officinalis soup etc. all wet to be contained to control with card compatibility with this product, cold-damp dysentery.Cortex Magnoliae Officinalis and the Radix Aucklandiae compatible, strengthen the merit of promoting the circulation of QI to relieve pain, improve the symptoms such as disease chicken poor appetite, diarrhoea.
Rhizoma Zingiberis, pungent, heat.Return spleen, stomach warp.This product is hot dry strong, and master enters taste and is longer than warming spleen and stomach for dispelling cold, strong activating the spleen sun, is the principal agent of warm middle Jiao.Shennong's Herbal: " hemostasis, perspires for main fullness in the chest cough with dyspnea, warming middle-JIAO, by rheumatism numbness, and intestinal Bleach dysentery.Survivor is especially good." " pearl sac ": " and Rhizoma Zingiberis its with having four: logical heart-yang, one also; Remove internal organs chronic diseases, two also; The cold sending out warp all, three also; Control the cold stomachache of sense, four also." side in add Rhizoma Zingiberis, both helped and controlled the cold of heat clearing away medicine, prevent and treat too cold and cool damage spleen sun, get again the effect of Rhizoma Zingiberis temperature fortune, make spleen wet easily remove.
Make a general survey of we, Herba Andrographis heat-clearing and toxic substances removing, Rhizoma Atractylodis dampness, the compatibility Radix Aucklandiae, Cortex Magnoliae Officinalis adjust smooth taste mechanism of qi, assistant, with needle warming moxibustion Rhizoma Zingiberis, had both helped the transporting of spleen, and had prevented heat-clearing and toxic substances removing again and do not hinder the foundation of acquired constitution, all medicines share plays heat-clearing and toxic substances removing, dampness circulation of qi promoting altogether, effect of solid protection taste, makes damp and hotly easily to remove, and gastrointestinal mechanism of qi is adjusted suitable, strengthen disease chicken immunity, alleviate escherichia coli disease symptoms.
In sum, the selection of this prescription has sufficient Chinese veterinarian's theoretical foundation: chicken colibacillosis is mainly in hot climate wet season, damp and hot inclined Sheng, chicken experiences Shi Re Bing Pian morbidity, pathogen is by the change of disease of epidemic febrile disease defensive-qi-nutrient-blood, and syndrome of WEI system performance feather is fluffy and disorderly, lethargy; Damp invasion of lower energizer large intestine, therefore performance aquiform stool and loose stool.Damp and hotly import edema caused by disorder of QI into, performance heating, breathe and breathe heavily thick, injure the five internal organs, be easy to dead.Severe patient pathogenic heat the pathogen attacking the pericardium adversely or go deep into blood system, we lotus perfume is loose tightly keeps above etiology and pathogenesis, when not falling ill, timely heat clearing and damp drying, dispel damp-heat disease because preventing morbidity, compatibility spleen invigorating circulation of qi promoting method for the treatment of, the gastrointestinal function of adjustment and enhancing chicken, improve immunity and the resistance of chicken self, thus reduce the sickness rate of colibacillosis.Strive prevention of diseae.In the morbidity course of disease, defend stage by stage, damp and hot Yong Sheng, incoordination between the spleen and stomach, large intestine conduction is not normal, shows as listless, and feed intake declines, feather is fluffy and disorderly, heat-clearing and toxic substances removing, dampness early when aquiform stool and loose stool, wetly do not go then heat not remove, regulating gastointestinal mechanism of qi simultaneously, prevent and treat damp and hot pathogen and enter the inner change of disease further, reduce the infringement after Colibacillosis.In addition, we inheriting damp eliminating heat clearing away, defend on basis that gas rules together, strengthen the power of dampness, and combine the protecting stomach-QI principle of " taste are ruled together ", strengthen and help strong fortune chicken spleen and stomach function Chinese medicine, with strengthening vital QI to eliminate pathogenic factors, treating both the principal and the secondary aspects of a disease at the same time.
The present invention has following beneficial effect:
The invention discloses the application of a kind of herbal medicine compound preparation in the medicine of preparation treatment chicken colibacillosis, this prescription Chinese medicine has extraordinary curative effect to chicken colibacillosis, effectively can control spreading and spreading of this disease, and safety, side effect are little, application prospect is good.
Make a general survey of we, Herba Andrographis heat-clearing and toxic substances removing, Rhizoma Atractylodis dampness, the compatibility Radix Aucklandiae, Cortex Magnoliae Officinalis adjust smooth taste mechanism of qi, assistant, with needle warming moxibustion Rhizoma Zingiberis, had both helped the transporting of spleen, and had prevented heat-clearing and toxic substances removing again and do not hinder the foundation of acquired constitution, all medicines share plays heat-clearing and toxic substances removing, dampness circulation of qi promoting altogether, effect of solid protection taste, makes damp and hotly easily to remove, and gastrointestinal mechanism of qi is adjusted suitable, strengthen disease chicken immunity, alleviate escherichia coli disease symptoms.
Experimental result shows, theoretical for foundation with sufficient Chinese veterinarian, and by reasonably composite, in South China of China, the curative effect of prescription Chinese medicine of the present invention to chicken colibacillosis is better than contrast medicine four taste Herba Andrographis and falls apart.Especially to high temperature, rainy, damp-heat area, therapeutic effect is good, speed is fast, and safety, side effect are little, can reach the effect for the treatment of both the principal and secondary aspects of a disease, significant to the aviculture in the subtropical climate areas such as China south China, have good economic implications and social meaning.
Accompanying drawing explanation
Fig. 1 is preparation technology's flow chart that lotus perfume is loose.
Detailed description of the invention
Further illustrate the present invention below in conjunction with Figure of description and specific embodiment, but embodiment does not limit in any form to the present invention.Unless stated otherwise, the present invention adopts reagent, method and apparatus are the art conventional reagent, method and apparatus.
Unless stated otherwise, agents useful for same of the present invention and material are commercial.
embodiment 1 the present invention treats preparation method and the lab scale craft of the herbal medicine compound preparation of chicken colibacillosis
1, preparation method
(1) prescription name: lotus perfume is loose.
Prescription: Herba Andrographis 167g, Rhizoma Atractylodis 250g, Radix Aucklandiae 167g, Cortex Magnoliae Officinalis 166g, Rhizoma Zingiberis 250g, makes 1000g.
(2) preparation method: above five kinds of Chinese crude drugs, are broken into coarse granule respectively, then in the mixing of prescription ratio, pulverize further, cross 30 mesh sieves, put in V-Mixer and mix 30 minutes, subpackage.
Dosage form: the dosage form of this herbal medicine compound preparation is powder.
(3) this lotus perfume is loose is made up of Herba Andrographis, Rhizoma Atractylodis, the Radix Aucklandiae, Cortex Magnoliae Officinalis and Rhizoma Zingiberis 5 taste medical material, wherein Rhizoma Atractylodis, the Radix Aucklandiae, Rhizoma Zingiberis 3 taste medical material are mainly containing volatile oil, inventor has investigated this 3 taste medical material water extraction and has received oily technique, found that oil yield lower (being about 0.53%); And the andrographolide in principal agent Herba Andrographis medical material is by thermally labile, is easily converted into dehydrorographolide, therefore determine that directly medical material being beaten powder is used as medicine.
2, lab scale craft
(1) flour extraction is investigated
Take the clean medical material of Herba Andrographis, Rhizoma Atractylodis, the Radix Aucklandiae, Cortex Magnoliae Officinalis and Rhizoma Zingiberis by recipe quantity, weigh 3 parts, every part of 10kg, pulverize, cross 30 mesh sieves, calculate flour extraction.Result is as shown in table 1.
The loose flour extraction of table 1 lotus perfume
(2) research before preparation prescription: the fragrant loose powder of lotus broken mistake 30 order, measure mobility, hygroscopicity, bulk density, granularity etc., result is as shown in table 2.Result shows, and the loose mobility of 30 order lotus perfume is better, and hygroscopicity is not strong.
The character of the loose raw material of table 2 lotus perfume
(3) adjuvant is selected: according to the character that lotus perfume is loose, its mobility is better, and hygroscopicity is not strong, add and use screw rod powder subpackage, less demanding to mobility, therefore need not use fluidizer, medicated powder gas is fragrant, bitter in the mouth, after mixed feeding, bitterness is not clearly, and chicken feels not obvious to bitterness, do not affect the feed of chicken, therefore need not add the adjuvant such as correctives, fluidizer.
(4) process route is selected: according to Chinese powder medicine preparations shaping process route, determines the loose production process route of lotus perfume as shown in Figure 1.
(5) preparations shaping technical study: lotus perfume (or spice) is dispersed in raw medicinal material pre-treatment research have been pulverized and sieved, and therefore preparations shaping technique mainly mixes and divided dose.
It is V-Mixer that powder mixes the most frequently used mixing apparatus, therefore uses V-Mixer to test, below tests the relation of paper examines incorporation time and mixing homogeneity and uniformity of dosage units, thus determine incorporation time.
The investigation of incorporation time: take the fragrant divided powder 20kg of lotus, mix 10 minutes at laboratory V-Mixer respectively, 20 minutes, 30 minutes time carry out sampling (sample point is respectively in the sampling of upper, middle and lower each point), check appearance uniform degree.Result is as shown in table 3.
Table 3 incorporation time investigates result
As shown in Table 3, mix 10 minutes, 20 minutes, 30 minutes appearance uniform degree qualified, appearance uniform degree does not have too big-difference, uniformity of dosage units and production feed intake scale and equipment relevant, follow-up Pilot scale runs shows, mixing 30 minutes uniformity of dosage units can be qualified, therefore considers the suitability of technique, and incorporation time selects be advisable for 30 minutes.
(6) subpackage: the lotus perfume getting mix homogeneously is loose, equipment debugging accurately after subpackage 30 bags, check by Minimum loading capacity examination method, all meet requirement under powder item.
3, process certification test
In process certification test, by the loose fixed recipe quantity of lotus perfume and technique, long run test 3 batches.Namely the fragrant loose powder of lotus is broken, is investigate project, the results are shown in Table 4 with flour extraction.
Table 4 lotus fragrant day labor skill demonstration test result
Result shows: adopt the loose flour extraction average of this technique lotus perfume to be 97.6%, technique favorable reproducibility, process stabilizing.
In sum, according to above research, determine that the preparation method that lotus perfume is loose is: get Herba Andrographis, Rhizoma Atractylodis, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Rhizoma Zingiberis five kinds of clean medical materials, be ground into coarse granule respectively, then in the mixing of prescription ratio, further fine powder is broken, cross 30 mesh sieves, put in V-Mixer and mix 30 minutes, subpackage, get final product (concrete process for producing as shown in Figure 1).
the loose quality standard of embodiment 2 lotus perfume
[
prescription name]
the loose Lian xiang san of lotus perfume
[
prescription] Herba Andrographis 167g, Rhizoma Atractylodis 250g Radix Aucklandiae 167g Cortex Magnoliae Officinalis 166g Rhizoma Zingiberis 250g.
[
method for making] above gomi herbs, pulverize, sieve, mixing, to obtain final product.
[
character] this product is lark powder; Gas is fragrant, bitter in the mouth.
[
function] heat-clearing and toxic substances removing, except humidifying stagnant.
[
cure mainly] for chicken colibacillosis.
[
specification] 250g/ bag.
[
usage and consumption] mixed feeding: every 1kg feedstuff, chicken 10g.
[
storage] sealing, moistureproof.
[
effect duration] 2 years.
[
differentiate] (1) get this product 6g, add methanol 100mL, soaked overnight, supersound process (power 360 W, frequency 40 kHz) 30min, filter, filtrate 60 DEG C of evaporates to dryness, the residue 15mL that adds water makes dissolving, cross AB-8 type macroporous adsorbent resin (post footpath 1.3cm, post height 15cm), wash with water to colourless, use 50mL 40% ethanol more respectively, 100mL 70% ethanol gradient elution, collect 70% ethanol elution, be evaporated to without alcohol taste, add water 20mL, 3 times are extracted with chloroform jolting, each 20mL, merge chloroform liquid, 60 DEG C of evaporates to dryness, residue adds ethyl acetate 1mL makes dissolving, as need testing solution.Separately get Herba Andrographis control medicinal material 2 g, add ethanol 30 mL, supersound process (power 360 W, frequency 40 kHz) 30 minutes, filter, filtrate 60 DEG C of evaporates to dryness, residue adds ethanol 2 mL makes dissolving, medical material solution in contrast.Test according to thin layer chromatography (" Chinese veterinary pharmacopoeia " 2010 editions two annex 32 pages), draw above-mentioned need testing solution 10 μ L, control medicinal material solution 8 μ l, put respectively on same GF254 lamellae, with chloroform-acetate-methanol (4:3:0.4) for developing solvent, launch, take out, dry, inspect under putting ultra-violet lamp (254 nm).In test sample chromatograph, on the position corresponding to control medicinal material chromatograph, the fluorescence speckle of aobvious same color.
(2) get this product powder 6g, add methanol 50mL, supersound process (power 360 W, frequency 40 kHz) 30 minutes, filter, filtrate reduced in volume is to thick paste, and the 30mL that adds water dissolves, 3 times are extracted with chloroform jolting, each 20 mL, merge chloroform liquid, 50 DEG C of evaporates to dryness, residue adds methanol 5mL makes dissolving, as need testing solution.Separately get Rhizoma Atractylodis control medicinal material 1g, add methanol 10mL, supersound process (power 360 W, frequency 40 kHz) 15 minutes, filter, get filtrate, in contrast medical material solution.Test according to thin layer chromatography (" Chinese veterinary pharmacopoeia " 2010 editions two annex 32 pages), draw need testing solution 6 μ L, control medicinal material solution 8 μ L, put respectively on same silica gel g thin-layer plate, with cyclohexane-ethyl acetate (22:1) for developing solvent, launch, take out, dry, spray is with 5% vanillin-sulfuric acid solution, and 105 DEG C to be heated to spot development clear.In test sample chromatograph, on the position corresponding to control medicinal material chromatograph, the speckle of aobvious same color.
(3) [discriminating] 2 lower need testing solutions are got as need testing solution.Separately get Radix Aucklandiae control medicinal material 1g, add methanol 20mL, supersound process (power 360 W, frequency 40 kHz) 30 minutes, filter, 50 DEG C of evaporates to dryness, residue adds methanol constant volume to 2mL, in contrast medical material solution.Separately get dehydrocostuslactone reference substance, costunolide reference substance, add methanol and make the solution of every 1mL containing 0.5mg respectively, product solution in contrast.Test according to thin layer chromatography (" Chinese veterinary pharmacopoeia " 2010 editions two annex 32 pages), draw need testing solution 3 μ L, control medicinal material solution 4 μ L under [discriminating] 2, two kinds of each 6 μ L of reference substance solution, put respectively on same silica gel g thin-layer plate, with toluene-methanol (27:1) for developing solvent, launch, take out, dry, spray is with 5% vanillin-sulfuric acid solution, and 105 DEG C to be heated to spot development clear.In test sample chromatograph, on the position corresponding with reference substance chromatograph to control medicinal material, the speckle of aobvious same color.
(4) get this product powder 6g, add methanol 50mL, supersound process (power 360 W, frequency 40 kHz) 30 minutes, filter, filtrate evaporate to dryness, residue adds dilute hydrochloric acid 40mL and dissolves, and extracts 3 times with chloroform jolting, each 20mL, merges chloroform liquid, extracts 3 times with 2%NaOH jolting, each 20mL, merges alkaline solution, adds hydrochloric acid and adjusts pH to 1 ~ 2, extract 3 times with chloroform jolting, each 20mL, merge chloroform liquid, evaporate to dryness, residue adds methanol 1mL and dissolves, as need testing solution.Separately get Cortex Magnoliae Officinalis control medicinal material 1g, add methanol 20mL, close plug, supersound process (power 360 W, frequency 40 kHz) 30 minutes, filter, evaporate to dryness, residue adds methanol constant volume to 2mL, in contrast medical material solution.Test according to thin layer chromatography (" Chinese veterinary pharmacopoeia " 2010 editions two annex 32 pages), draw above-mentioned need testing solution 5 μ L, control medicinal material solution 3 μ L, put respectively on same silica GF254 lamellae, with cyclohexane-acetone (7:2) for developing solvent, launch, take out, dry, inspect under putting ultra-violet lamp (254 nm).In test sample chromatograph, on the position corresponding to control medicinal material chromatograph, the fluorescence speckle of aobvious same color.
[
check] powder item should be met under relevant every regulation (" Chinese veterinary pharmacopoeia " 2,010 two annex 5 pages).
[
assay] andrographolide, dehydrorographolide, costunolide and dehydrocostuslactone
content according to high performance liquid chromatography " Chinese veterinary pharmacopoeia " 2010 editions two annex 34 pages of mensuration.
Chromatographic condition and system suitability: be filler with octadecylsilane chemically bonded silica, take methanol as mobile phase A, water is Mobile phase B, carries out gradient elution according to table 5; Dehydrorographolide determined wavelength is 254 nm, and andrographolide, costunolide, dehydrocostuslactone all detect under 225 nm.Theoretical cam curve is not less than 3000.
Table 5 gradient elution table
The preparation of reference substance solution: get andrographolide, dehydrorographolide, costunolide and dehydrocostuslactone reference substance respectively appropriate, accurately weighed, add methanol and make the mixing reference substance solution of every 1mL containing andrographolide 50 μ g, dehydrorographolide 50 μ g, costunolide 100 μ g, dehydrocostuslactone 150 μ g, to obtain final product.
The preparation of need testing solution: get this product content under content uniformity item, about 3g, accurately weighed, put in tool plug conical flask, precision adds methanol 50 ml, weighed weight, supersound process (power 360 W, frequency 40 kHz) 30 minutes, let cool, more weighed weight, the weight of less loss is supplied with methanol, shake up, filter, get subsequent filtrate, to obtain final product.
Algoscopy: accurate absorption reference substance solution and each 10 μ L of need testing solution respectively, injection liquid chromatography, measures, to obtain final product.This product is containing the Radix Aucklandiae with the total amount of costunolide and dehydrocostuslactone, and every g must not be less than 2.5mg, and containing Herba Andrographis with the total amount of andrographolide and dehydrorographolide, every g must not be less than 1.0mg.
In sum, quality research have employed the index components consistent with technical study and controls, and in prescription, whole medical material all establishes the thin layer chromatography method of inspection, and Herba Andrographis, the Radix Aucklandiae, Cortex Magnoliae Officinalis three taste principal agent all establish high performance liquid chromatography content assaying method simultaneously; Above-mentioned quality research result is that the controllability of this product provides support; Results of stability confirms the stable controllability of this product.
embodiment 3 pilot process
The loose scale up test of lotus perfume is carried out according to the technique of embodiment 1, take recipe quantity 20 times of medical materials respectively, undertaken pulverizing by the loose preparation technology of lotus perfume, sieve, mix, subpackage, pick test, by production technology scale up test 10 batches of products of embodiment 1, and detect according to embodiment 2 " the loose quality standard of lotus perfume " related request, result is as shown in table 6 ~ 8.
Table 6 pilot-scale experiment
Table 7 pilot-scale experiment
Table 8 pilot-scale experiment
According to the data of above pilot process, technology controlling and process is carried out according to the scheme of pilot scale, with andrographolide, dehydrorographolide, costunolide, dehydrocostuslactone for index, tracking evaluation pilot process, result shows, production technology is smooth, simple and feasible, composition retention rate is high, and pilot product is through being up to the standards, and quality has has all met or exceeded laboratory level, explanation enlarged experiment is feasible, have operability, can instruct to amplify and produce, its cost control is suitable with ordinary powder cost.Point out this preparation technology's reasonable, be suitable for producing.
embodiment 4 pharmacodynamic experiment is studied
The present embodiment carries out the pharmacodynamic experiment research of medicine of the present invention, and all test datas adopt SAS 9.2 to carry out statistical analysis, carry out variance analysis (analysis of variance, ANOVA) or Kruskal-Wallis rank test.Data with means standard deviation (
± SD) represent, P<0.05 is significant difference, and P<0.01 is and significant difference.
1, experiment material
(1) experimental animal: SPF level KM mice, body weight 20 ± 2g, ♀ ♂ half and half, is provided by Traditional Chinese Medicine University Of Guangzhou's Experimental Animal Center, (quality certification SCXK(Guangdong) 2013-0002).Divide cage routine to raise, raising temperature is 25 ~ 35 DEG C, and humidity is 60%, raises with solid feed, freely drinks water.
(2) test sample:
The loose sample of lotus perfume, Guangzhou Experimental Veterinary Medicine Co., Ltd. of South China Agricultural University provides, lot number: 2013030103(is according to the above-mentioned production technology preparation of the present invention).
Folium Sennae (lot number: YPA3A0001 is purchased from Guangzhou Cai Zhilin Pharmaceutical chain store)
Loperamide hydrochloride capsules, specification: 2mg, (lot number: 130219290, Xian-Janssen Pharmaceutical Ltd.)
Oleum Ricini, Tianjin good fortune chemical reagent factory in morning, lot number: 20130427
Berberine Hydrochloride Tablets, Guangdong Huanan Pharmaceutical Co., Ltd, lot number: 20131214
Escherichia coli O
78, purchased from China Veterinery Drug Inspection Office.
20121228), agar powder (lot number:: 20121020) producer is Qingdao GaoKeYuan Hai Bo biotech company 20130530), brain heart infusion broth BHI(lot number nutrient broth (lot number:
(3) test sample process:
The preparation of the fragrant aproll extract of lotus: get the loose 62.5g of lotus perfume respectively, 50g, 40g, every portion adds 9,6 times amount water extraction twice respectively, extraction time is 1.5h, 1h, each time medicinal liquid filters, and is concentrated into the gradient concentration medicinal liquid making 0.625g/ml, 0.5g/ml, 0.4g/ml after merging in 85 DEG C with Rotary Evaporators, for subsequent use in 4 DEG C of Refrigerator stores.
The preparation of Folium Sennae leachate: before use, takes Folium Sennae 10g(and crosses 20 mesh sieves), with 10 times amount distilled water, soak 0.5h in 90 DEG C, get filtrate reduced in volume to 0.1g/ml medicinal liquid.
The preparation of loperamide hydrochloride solution: take loperamide hydrochloride 4mg, adds appropriate distilled water, and after ultrasonic dissolution, adding distil water is joined final concentration is 0.1mg/ml medicinal liquid, saves backup in 4 DEG C.
The preparation of berberine hydrochloride solution: get Berberine Hydrochloride Tablets 10 (altogether hydrochloric berberine 1g), add appropriate distilled water, after ultrasonic dissolution, adding distil water is joined final concentration is 1.5mg/ml medicinal liquid, saves backup in 4 DEG C.
Charcoal end suspension: take 5g active carbon, 1g sodium carboxymethyl cellulose, mix with 100ml distilled water, fully after stirring and get final product.
The preparation of BHI fluid medium: take brain heart infusion broth BHI dry powder 3.85g in conical flask, add 100mL double distilled water, and use turbula shaker shaken well, for subsequent use after autoclaving.
The preparation of BHI solid medium: take BHI dry powder 11.55g, agar powder 4.5g in conical flask, adds 300mL double distilled water turbula shaker shaken well, for subsequent use after being sub-packed in glass plate after autoclaving.
(4) instrument and equipment
Vacuum pump using circulatory water SHZ-D (III) (Yuhua Instrument Co., Ltd., Gongyi City, maximum vacuum/Mpa:0.098);
The two outstanding T1000 electronic balance (Shuan Jie test instrunment factory of Changshu City, product type T1000) of the G & G U.S.;
EYELA SB-1000 type Rotary Evaporators (Shanghai Ai Lang Instrument Ltd.);
TC-15 jacket formula heating thermostat (Haining City Xinhua District medical apparatus and instruments factory);
High-pressure steam sterilizing pan (Shanghai Sanshen Medical Instrument Co., Ltd.);
Constant incubator (pond this physics and chemistry industry Co., Ltd.);
Air bath agitator (Dong Lian electronics technology development corporation, Ltd. of Harbin City).
2, lotus perfume is loose tests the impact of Folium Sennae diarrhea mice
(1) experiment grouping: the KM mice 60 of getting 20 ± 2g, ♀ ♂ half and half, random packet is blank group, model group, positive drug group, the loose high, medium and low dosage group of lotus perfume, often organize 10.
The loose high, medium and low dosage group of lotus perfume presses the corresponding medicinal liquid of 0.2mL/10g gavage, positive drug group is with 0.2mL/10g gavage Loperamide Hydrochloride solution, blank group, model group are to equal-volume distilled water, administration 5d altogether, before modeling, fasting be can't help water and is spent the night, test the same day according to the modeling of 0.2mL/10g body weight gavage Folium Sennae extracting solution, blank group to equal-volume distilled water, after modeling 30min each treated animal give corresponding medicinal liquid.
(2) start observed and recorded after administration 1h, 4h observed by each treated animal list cage, and lower berth filter paper is done wetly just to count, and per hourly changes a filter paper.The accumulative wet just number of record, wet just level, and calculate each treated animal Scours index.
Loose stool rate: loose stool number/total just number that every animal is arranged
Scours index: loose stool rate × loose stool level
Loose stool level: the degree representing loose stool, pollute with loose stool the size deciding grade and level that paper forms stain area (polluting diameter cm), be divided into 4 grades, standard progression is as follows:
Table 9 mice loose stool level (unit: cm)
(3) experimental result is as shown in table 10
The loose impact (n=10, x ± s) on Folium Sennae Diarrhea Model mice of table 10 lotus perfume
Result shows, and the loose height of each lotus perfume, middle dosage group all can obviously reduce model mice Scours index, have obvious anti-diarrhea effect.
3, lotus perfume is loose tests the impact of Oleum Ricini diarrhea mice
Operate according to the method for above-mentioned 2nd (lotus perfume is loose tests the impact of Folium Sennae diarrhea mice), modeling reagent is to the modeling of same volume Oleum Ricini.
Lotus perfume is loose as shown in table 11 to the result of the test of Oleum Ricini diarrhea mice.
The loose impact (n=10, x ± s) on Oleum Ricini Diarrhea Model mice of table 11 lotus perfume
Result shows, and the loose height of each lotus perfume, middle dosage group all can obviously reduce model mice Scours index, have obvious anti-diarrhea effect.
4, lotus perfume is loose to escherichia coli O
78cause the impact of peritonitis
(1) escherichia coli O
78the preparation of suspension:
Take the logarithm the escherichia coli O of trophophase
78be inoculated in nutrient agar panel, put 37 DEG C of constant incubators and cultivate 24h, the single bacterium colony of picking turns in nutrient broth, cultivates 18h for 37 DEG C, measure bacterial concentration with Maxwell opacity tube in water bath with thermostatic control agitator, and is 3.0 × 10 with normal saline adjustment bacterial concentration
8cFU/mL.By bacterium liquid (by the weight of animals 0.01mL/g) and containing 10% BaSO
4meat soup press 1:1 mixing, be modeling suspension.
(2) divide into groups: the KM mice 60 of getting 20 ± 2g, ♀ ♂ half and half, random packet is blank group, model group, positive drug group, the loose high, medium and low dosage group of lotus perfume, often organize 10.
The loose high, medium and low dosage group of lotus perfume press the corresponding medicinal liquid of 0.2mL/10g gavage, positive drug group with 0.2mL/10g gavage berberine hydrochloride solution, blank group, model group to equal-volume distilled water, common administration 5d.Before modeling, fasting be can't help water and is spent the night, and each group of the same day of test is according to 0.01mL/g lumbar injection escherichia coli O
78suspension modeling, blank group to equal-volume normal saline, after modeling each treated animal of 30min give corresponding medicinal liquid.
(3) start each treated animal death condition of observed and recorded after administration, dead animal is dissected, and observes 1 week altogether.
(4) result is as shown in table 12.
The loose impact (n=10) on escherichia coli type peritonitis mice of table 12 lotus perfume
Result shows, and the loose height of lotus perfume, middle concentration group can reduce escherichia coli fatality rate, have good protective effect.
5, the loose impact on mice Intestinal pushing function of lotus perfume
(1) divide into groups: the KM mice 50 of getting 20 ± 2g, ♀ ♂ half and half, high, medium and low dosage group that random packet is blank group, positive drug group, lotus perfume fall apart, often organizes 10.
The loose high, medium and low dosage group of lotus perfume presses the corresponding medicinal liquid of 0.2mL/10g gavage, blank group to equal-volume distilled water, positive drug group to 0.2mL/10g gavage Loperamide Hydrochloride solution, altogether administration 5d, before modeling, fasting be can't help water and is spent the night, after test administration on same day 1h, each group of gavage gives 5% charcoal end suspension 0.2mL/10g, put to death animal after 20min, open abdominal cavity and be separated mesentery, get the intestinal tube of pylorus to ileocecus, measure total small intestinal length and charcoal end advance distance, and calculate propelling rate.
Charcoal end propelling rate=charcoal end advance distance/total small intestinal length × 100%
(2) result is as shown in table 13.
The loose impact (n=10, x ± s) on mice Intestinal pushing of table 13 lotus perfume
Note: *: compare with blank group, P < 0.05; *: compare with blank group, P < 0.01.
Result shows, and the loose height of lotus perfume, middle concentration group all obviously can suppress mice Intestinal pushing function.
6, in sum, this result of the test shows, can effectively reduce by reagent lotus perfume is loose the mortality rate that escherichia coli cause peritonitis mice; Suppress the diarrhoea of Folium Sennae and Oleum Ricini Diarrhea Model mice simultaneously effectively, be wherein excellent with high, middle dosage group, also can suppress Intestinal motility; Also for veterinary drug clinical trial provides foundation, the herbal medicine of anti-colibacillosis can be developed further.
the experimental clinical research of embodiment 5
According to " veterinary Chinese medicine, natural drug clinical trial technological guidance principle ", the loose prevention effect to test chicken artificial challenge colibacillosis of Study of Traditional Chinese Medicine lotus perfume and best dosage, for the concrete dosage regimen in Control of Colibacillosis of Chickens work common in clinical poultry provides test data and scientific basis.
1, experiment material
(1) experimental animal: 1 age in days Lingnan Yellow commercial broiler flocks, purchased from Guangdong Wiz Agricultural Science & Technology Co., Ltd..
(2) test drug: lotus perfume is loose: Guangzhou Experimental Veterinary Medicine Co., Ltd. of South China Agricultural University provides, lot number: 2013030102(is according to the above-mentioned production technology preparation of the present invention).
Four taste Herba Andrographis fall apart, and Guangzhou Experimental Veterinary Medicine Co., Ltd. of South China Agricultural University provides, lot number: 2013121301.
(3) test apparatus: constant incubator, Shanghai leap medical apparatus and instruments factory produces; Aseptic operating platform, Suzhou hundred million reaches cleaning laboratory equipment company limited and produces.
(4) strain: strains tested is chicken colibacillosis O
78(purchased from China Veterinery Drug Inspection Office, lot number: CVCC1569).
(5) experimental animal basal diet: with reference to NRC(1994 version) feeding of broiler standard and China Broiler feeding standard preparation basal diet in 1998, not drug containing additive in basal diet.
2, the preparation of test organisms and counting
By chicken colibacillosis (O
78serotype) inoculate ordinary flat, after 37 DEG C of cultivation 24 h, select colonies typical and be inoculated in meat soup, take out after cultivating 18 h through 37 DEG C again.By this broth culture inoculation chicken, also can by lethal for inoculation chicken in the hope of its pathogenicity rejuvenation.Inoculating slat chain conveyor from the liver separating Escherichia coli of dead chicken, finally select colonies typical ordinary broth and cultivate, adopt colony counting method to carry out colony counting, is 2 × 10 containing bacterium number by the dilution of bacterium liquid
9cfu/mL, for subsequent use.In the clinical symptoms of inoculation fore-and-aft observing chicken, cut open the dead chicken of inspection, get liver, spleen and heart and carry out bacteria distribution cultivation and qualification, to determine whether successfully to induce an illness.
3, the foundation of artificial challenge's chicken colibacillosis pathological model
By 0.2 × 10
9cfu/mL ~ 1 × 10
9bacterial concentration between cfu/mL is adjusted to 9 concentration groups, is respectively 0.2 × 10
9cfu/mL, 0.3 × 10
9cfu/mL, 0.4 × 10
9cfu/mL, 0.5 × 10
9cfu/mL, 0.6 × 10
9cfu/mL, 0.7 × 10
9cfu/mL, 0.8 × 10
9cfu/mL, 0.9 × 10
9cfu/mL and 1 × 10
9cfu/mL.Often organize 20 chickling, every chicken each lumbar injection counteracting toxic substances bacterium liquid 0.5mL.Separately set one group as normal healthy controls group.The state of chickling after observation counteracting toxic substances, record chicken death number of elements.
Result of the test shows, with 0.6 × 10
9cfu/ml and 0.7 × 10
9cfu/ml, every chicken lumbar injection 0.5ml, test chicken 100% can be made to fall ill, present typical chicken colibacillosis clinical symptoms, fatality rate is 65%.Therefore, escherichia coli O in experiment can be inferred
78strain is to the LD of chickling artificial challenge on the 10th
500.2 ~ 0.6 × 10
9between cfu/ml.In formal counteracting toxic substances process, this test and Selection concentration is 0.6 × 10
9the 0.6ml Escherichia coli bacteria liquid of cfu/ml is as the counteracting toxic substances dosage setting up chicken escherichia coli infection model.
4, experimental animal grouping and process
Test packet transaction situation is in table 14.By 150 1 age in days test chickens, when raising to 10 age in days, choose 120 close test chickens of healthy weight, be divided into 6 groups at random, often organize 20.1st ~ 3 groups is that test medicine group (infects, test medicine is treated), wherein the 1st group is low dosage (0.5% lotus perfume is loose) treatment group, and the 2nd group is middle dosage (1% lotus perfume is loose) treatment group, and the 3rd group is high dose (2% lotus perfume is loose) treatment group, 4th group is that control drug group (infects, to fall apart control drug to 0.5% 4 taste Herba Andrographis), the 5th group for infecting matched group (infecting, not administration), 6th group be normal healthy controls group (not infecting, not administration) and with the isolated rearing of 1-5 group.To every test chicken inoculation chicken colibacillosis (O of 1st ~ 5 groups
78serotype) meat soup bacterium liquid 0.6 ml/, the 6th group of injection normal saline.Namely carry out process dispensing by table 1 after counteracting toxic substances, 1-4 group is dispensing 7 d continuously, observe 14 d to inoculation.At duration of test test chicken free choice feeding, drinking-water, and program carries out epidemic disease immunity, hygienic cleaning and sterilization routinely.
Table 14 tests grouping and disposition
5, the main Testing index of duration of test and result
Test data represents with (mean+SD), and applies SPSS statistical analysis software and carry out statistical analysis and process.
(1) the clinical growth of test chicken and onset state etc. after manual-induced broiler colibacillosis
Examine the clinical manifestation situations such as test chicken is searched for food, drunk water, diarrhoea in duration of test every morning, afternoon and do itemized record, and recording test chicken death time and quantity, pathological anatomy being carried out to death experiments chicken and bacteria distribution is cultivated.
Result of the test shows, and other 5 the infected group test chickens except the 6th group start morbidity after counteracting toxic substances 6 h, shows as lassitude, dirty and messy by hair, inverse vertical, flocks together, necking down, wing are sagging, row's HUANGBAI(sic) loose stool, drink loss of appetite.Cut open the dead chicken of inspection, observe viscera, main manifestations is perihepatitis and pericarditis, liver enlargement, hyperemia, severe patient liver surface has fibrous exudate, and air bag thickens, muddiness, Glisson's capsule thickens and has petechia or hemorrhage band, and pericardium thickens, and small intestinal mucosa has petechia.A large amount of typical escherichia coli are all isolated from liver, spleen and heart.
Result of the test shows, by tests such as test chicken clinical symptoms, bacteria distribution cultivations, determines successfully to bring out chicken colibacillosis in this test.
(2) the loose observation of curative effect to test chicken colibacillosis of lotus perfume
The recovery situation of duration of test record test chicken after morbidity after Drug therapy, record and the sickness rate, mortality rate, cure rate, effective percentage, the inefficiency that calculate test chicken.
Mortality rate: at duration of test, affected animal occurs that the classical symptom of chicken colibacillosis is also dead, and necropsy has the characteristics of lesion of typical chicken colibacillosis, and separation and Culture goes out chicken colibacillosis from liver, spleen and heart, be judged to infect death, and calculate mortality rate according to death toll gauge.
Cure rate: at duration of test, the affected animal mental status, appetite after administration recover normal, and the clinical symptoms such as excrement that no longer occur having loose bowels all belong to healing, and calculate cure rate according to healing quantity.
Effective percentage: at duration of test, affected animal its clinical symptoms after administration has obvious alleviator, is judged as effectively, and calculates effective percentage according to its quantity.
Inefficiency: at duration of test, affected animal its clinical symptoms after administration has no obvious improvement, and add severe one even to some extent, it is invalid to be judged as, and calculates effective percentage according to its quantity.
The loose therapeutic outcome to artificial challenge's chicken colibacillosis test broiler of Chinese medicine lotus perfume is as shown in Table 15.
(unit: only) added up by table 15 respectively group test chicken death time and number of elements
Result of the test shows, about 6 h after inoculation chicken colibacillosis, and clinical symptoms appears in total Test chicken, and sickness rate is 100%, and after treating 7 d through use various dose Chinese powder medicine, each test group chicken death time and number of elements are in table 15.Result shows, and 4 d have merely hit 12 and all concentrated on front 4 d test chicken death most time of concentration, particularly the 5th group of (infection matched group) test chicken death toll 13 before the test, account for more than 90% of dead sum; And 1st ~ 4 groups (infecting, treatment) account for about 70% of total death toll at the dead number of elements of front 4 d.Meanwhile, after the 8d of experimental period, all there is not dead chicken in each test group.
Concrete efficacy data statistical result is shown in table 16.
The loose curative effect to test chicken colibacillosis of table 16 lotus perfume
Note: # represents that the infection matched group test chicken oneself of not offeing medicine crosses situation to disease is resistance to.
Result of the test display (see table 8), the 6th group of (normal healthy controls group) test chicken sickness rate is for be 0% with mortality rate, and the 5th group of (infection matched group) test chicken mortality rate is 65%, apparently higher than the mortality rate (see table 3) of 1st ~ 4 groups (infecting, treatment group); Wherein, the mortality rate of the 2nd, 3 group (1% lotus perfume falls apart, 2% lotus perfume falls apart) is all lower than the 1st, 4 group (0.5% lotus perfume is loose, four taste Herba Andrographis are loose).5th group of test chicken inefficiency is all apparently higher than 1st ~ 4 groups; 5th group of (infection matched group) test chicken spontaneous recovery rate is 15%, all be starkly lower than 1st ~ 4 groups (to infect, treatment group), wherein, the cure rate of the 2nd, 3 group (1% lotus perfume falls apart, 2% lotus perfume falls apart) and effective percentage are all higher than the 1st, 4 group (0.5% lotus perfume is loose, four taste Herba Andrographis are loose).
Result of the test shows, when adding respectively in test chicken basal diet, lotus perfume is loose, four taste Herba Andrographis fall apart, and all significantly can reduce the mortality rate of artificial infection chicken's coli test chicken, and can improve its cure rate and effective percentage; Meanwhile, it is best to the curative effect of infected chicken when, 2% lotus perfume loose at interpolation 1% lotus perfume is loose.
(3) test chicken Gain weight
On-test with at the end of, to test chicken by only weighing, calculate each group of test chicken average weight.
The each group of impact of medicine on test chicken body weight is shown in table 17.
Table 17 is group test chicken body weights after off-test respectively
Note: with difference between capitalization different in string extremely significantly (p<0.01), significant difference (p<0.05) between different lower case.
Result of the test shows, when on-test, and each test group chicken average weight zero difference (96 ± 1g), find when off-test calculates survival test chicken body weight, whole infected group test chicken body weight is all remarkable in the 6th group (normal healthy controls group); Wherein, 1st ~ 4 groups of (infecting, treatment group) test chicken body weight are significantly higher than the 5th group (infection matched group).
Result of the test shows, when adding respectively in test chicken basal diet, lotus perfume is loose, four taste Herba Andrographis fall apart, and all has and promotes the resistance to mistake of artificial infection chicken coli test chicken and the effect better recovered, and can improve the upgrowth situation of test chicken; Wherein, the effect of the 2nd, 3 group (1% lotus perfume falls apart, 2% lotus perfume falls apart) is better than the 1st, 4 group (0.5% lotus perfume is loose, four taste Herba Andrographis are loose).
(4) inspection is dissected
After off-test, get each group of test chicken at random from each test group and analyse, and record relevant anatomy data.
Result of the test display, infects and the liver, heart, pericardium, small intestinal etc. of survival test chicken has no obvious pathological changes or have slight pathological changes after Drug therapy; And infect but all there is obvious pathological changes in the liver, heart, kidney, small intestinal etc. of untreated 5th group of test chicken.
Result of the test shows, when adding respectively in test chicken basal diet, lotus perfume is loose, four taste Herba Andrographis fall apart, and all can promote that artificial infection chicken's coli test chicken better recovers, and can alleviate effect of test chicken lesion tissue.
6, in this test, by manual-induced test chicken colibacillosis, and observe lotus perfume loose (high, medium and low dosage), four taste Herba Andrographis fall apart to the curative effect of infected chicken, paper examines index comprises: test chicken clinical symptoms performance situation, sickness rate, mortality rate, cure rate, effective percentage and inefficiency, and test chicken before the test after average weight, survival test chicken analyses the indexs of correlation such as pathological change.
Result of the test shows, and chicken colibacillosis is brought out in this success of the test, and morbidity chicken main manifestations is lassitude, dirty and messy by hair, inverse vertical, flocks together, necking down, wing are sagging, row's HUANGBAI(sic) loose stool, drink loss of appetite.Cut open the dead chicken of inspection, observe viscera, main manifestations is perihepatitis and pericarditis, and pericardium thickens, and small intestinal mucosa has the main pathological changes such as petechia, and all isolates a large amount of typical escherichia coli from liver, spleen and heart.
When adding respectively in test chicken basal diet, lotus perfume falls apart (high, medium and low dosage), four taste Herba Andrographis fall apart, all Chinese powder medicines all obviously can reduce the mortality rate of artificial infection chicken's coli test chicken, and its cure rate and effective percentage can be improved, alleviate test chicken main organs pathological changes, promote that test chicken resistance to mistake reaches healing with better getting well, improve the upgrowth situation of test chicken, the effect such as to put on weight.Meanwhile, comparative test result shows, is better than the loose and four taste Herba Andrographis of 0.5% lotus perfume falls apart when, 2% lotus perfume loose at interpolation 1% lotus perfume is loose to the curative effect of artificial infection chicken's coli test chicken.
In sum, this result of the test shows, when adding lotus perfume and be loose in basal diet, significantly can reduce the mortality rate of artificial infection chicken's coli test chicken, and its cure rate and effective percentage can be improved, promote the resistance to mistake of test chicken and better recovery, alleviate the lesion tissue of test chicken main organs, with the upgrowth situation improving test chicken.Comparative test result shows, when adding in basal diet that 1% lotus perfume is loose, 2% lotus perfume is loose respectively, being all better than loose and four tastes of interpolation 0.5% lotus perfume wearing lotus and fall apart the curative effect of infected chicken.
embodiment 6 expands clinical trial
According to " veterinary Chinese medicine, natural drug clinical trial technological guidance principle ", the loose prevention effect to chicken colibacillosis natural cases clinically of Study of Traditional Chinese Medicine lotus perfume and best dosage, for the concrete dosage regimen in Control of Colibacillosis of Chickens work common in clinical poultry provides test data and scientific basis.
1, experiment material
(1) experimental animal: 28 ~ 35 week age Roman egghen, Yunfu City: original breeding layer chicken company limited of Luoding City.
(2) test drug: lotus perfume is loose: Guangzhou Experimental Veterinary Medicine Co., Ltd. of South China Agricultural University provides, lot number: 2013030102(is according to the above-mentioned production technology preparation of the present invention).
Four taste Herba Andrographis fall apart, and Guangzhou Experimental Veterinary Medicine Co., Ltd. of South China Agricultural University provides, lot number: 2013121301.
(3) test apparatus: constant incubator (Shanghai leap medical apparatus and instruments factory produces); Aseptic operating platform (Suzhou hundred million reaches cleaning laboratory equipment company limited and produces).
(4) experimental animal basal diet: with reference to NRC (1994) laying hen nutrition requirements preparation basal diet, not drug containing additive in daily ration.
2, the choosing and making a definite diagnosis of hens salpingitis type escherichia coli natural cases in clinical cultivation
The raw Jiang Danjiyangzhichang of original breeding layer chicken company limited in Luoding City, chooses clinical signs and goes out spiritual tired, row's brown or white fecal pollution anus, day by day become thin, egg drop reduction or stopping, producing abnormal-shape egg, the sick chicken of the clinical symptoms such as eggshell color is thin out and frangible.Carry out pathology cut open inspection visible: theca folliculi distortion, hyperemia and hemorrhage, some follicles are taupe; Tunica mucosa tubae uterinae is congested, swelling, and fallopian tube is thicker, and quality becomes fragile, rotten to the corn thinning, inside has yellow-white caseous substance and other secretions.
Carry out laboratory bacterial separation and Culture: get cheesy agglomerate pathological material of disease in fallopian tube and rule on nutrient agar panel, 37 DEG C of constant temperature culture 24 hours, present the colony growth that a kind of form is homogeneous, be characterized as circular protrusions, neat in edge, smooth moistening, semi-transparent clear and diameter 1 ~ 2 mm.Its pure culture inoculation eosin methylene blue agar is dull and stereotyped, and bacterium colony is atropurpureus, band metallic luster; Connect maconkey agar flat board, bacterium colony is shiny red.
According to above clinical symptoms, analyse pathological change and to share with laboratory bacterial and cultivate and qualification, making a definite diagnosis disease chicken is the hens salpingitis disease that escherichia coli cause.
3, experimental animal grouping and process
Test packet transaction situation is in table 18.Choose the laying hen 100 suffering from salpingitis type colibacillosis, be divided into 2 groups at random, often organize 50.1st group is the loose treatment group of lotus perfume, the 2nd group of control drug treatment group (four taste Herba Andrographis fall apart).And process by described in table 1, dispensing 7 d, observe 14 d to medication continuously.Duration of test test chicken free choice feeding, drinking-water, and program carries out epidemic disease immunity, hygienic cleaning and sterilization routinely.
Table 18 tests grouping and administrations
4, testing inspection index and result
Test data represents with (mean+SD), and applies SPSS statistical analysis software and carry out statistical analysis and process.
(1) laying hen clinical manifestation after treatment by Chinese herbs is tested
Examine the clinical manifestations such as test chicken is searched for food, drunk water, diarrhoea in duration of test every morning, afternoon and do itemized record, record test chicken death time and quantity, pathological anatomy being carried out to dead chicken and bacteria distribution is cultivated.This test median oviduct scorching type colibacillosis natural occurrence laying hen respectively, four taste Herba Andrographis loose through Chinese powder medicine lotus perfume is treated 7d and observes 14d.
Result of the test shows, and along with the prolongation for the treatment of by Chinese herbs time, laying hen spirit is recovered to some extent, symptom of having loose bowels alleviates gradually, drink wish increases, and particularly egg laying performance improves gradually, and death stops gradually.
By the sick chicken of death is carried out pathology cut open inspection visible: theca folliculi distortion, hyperemia and hemorrhage, some follicles are taupe; Tunica mucosa tubae uterinae is congested, swelling, and fallopian tube is thicker, and quality becomes fragile, rotten to the corn thinning, inside has yellow-white caseous substance and other secretions.Carry out laboratory bacterial separation and Culture: get cheesy agglomerate pathological material of disease in fallopian tube and rule on nutrient agar panel simultaneously, 37 DEG C of constant temperature culture 24 hours, present the colony growth that a kind of form is homogeneous, be characterized as circular protrusions, neat in edge, smooth moistening, semi-transparent clear and diameter 1 ~ 2 mm.Its pure culture inoculation eosin methylene blue agar is dull and stereotyped, and bacterium colony is atropurpureus, band metallic luster; Connect maconkey agar flat board, bacterium colony is shiny red.According to morbidity laying hen clinical symptoms, analyse pathological change and to share with laboratory bacterial and cultivate and identify, making a definite diagnosis laying hen is the death that hens salpingitis disease that escherichia coli cause causes.
Result of the test shows, Chinese powder medicine lotus perfume is loose, four taste Herba Andrographis all have the clinical symptoms improving the hens salpingitis type disease that escherichia coli cause, and promotes that disease chicken gets well.
(2) curative effect of medication
Duration of test record morbidity test chicken at the recovery situation after Drug therapy, and calculates mortality rate, cure rate, effective percentage, inefficiency.
Mortality rate: at duration of test, there is typical Chicken salpingitis colibacillosis clinical symptoms and dead in affected animal, pathology cuts open inspection and finds: theca folliculi distortion, congested and hemorrhage, and some follicles are taupe; Tunica mucosa tubae uterinae is congested, blood stasis, and rotten to the corn thinning, quality becomes fragile, and inside has faint yellow albumen deposit; And a large amount of typical escherichia coli isolated by cheesy agglomerate pathological material of disease in fallopian tube, and calculate mortality rate according to death toll gauge.
Cure rate: at duration of test, affected animal after administration the mental status, appetite, to lay eggs etc. and all recover normal person and belong to healing, and calculate cure rate according to its quantity.
Effective percentage: at duration of test, affected animal its clinical symptoms after administration has obvious alleviator, is judged as effectively, and calculates effective percentage according to its quantity.
Inefficiency: at duration of test, affected animal its clinical symptoms after administration has no obvious improvement, and add severe one even to some extent, it is invalid to be judged as, and calculates effective percentage according to its quantity.
Each group of Chinese medicine to the efficacy result of morbidity test chicken as shown in table 19,20.
Respectively the group test chicken death time adds up (unit: only) to table 19
Result of the test shows, 1st, 2 test group laying hens through treatment by Chinese herbs 7d(experimental observation to treatment after 14d) after, phase (10d) has dead chicken to occur always before the test, but test chicken stops dead during 11st ~ 14d, wherein the 1st group (lotus perfume loose treatment group) at duration of test altogether dead 5 (10%), the 2nd group (four taste Herba Andrographis fall apart treatment group) at whole duration of test altogether dead 6 (12%).
Result of the test shows, salpingitis type colibacillosis natural occurrence laying hen is after treatment by Chinese herbs 7d, and the test chicken state of an illness takes a turn for the better all to some extent, dead minimizing.
The loose curative effect to test chicken colibacillosis of table 20 lotus perfume
Result of the test shows, and the 1st, 2 test group laying hens are after treatment by Chinese herbs 7d, and in the whole experimental observation phase, the loose treatment group mortality rate of lotus perfume is 10%, the four taste Herba Andrographis treatment group mortality rate that falls apart is 12%; The loose treatment group cure rate of lotus perfume is 52%, and it is 82% that cure rate adds effective percentage; The four taste Herba Andrographis treatment group cure rate that falls apart reaches 48%, and it is 76% that cure rate adds effective percentage.
Result of the test shows, salpingitis type colibacillosis natural occurrence laying hen is observing 14d through treatment by Chinese herbs 7d, and the test chicken state of an illness takes a turn for the better all to some extent, deadly reduces, part test chicken reaches criterion of cure, shows that lotus perfume is loose to the equal tool therapeutical effect of colibacillosis.
(3) test chicken laying rate and Egg Quality situation of change
Calculate each group of test laying hen egg production every day and calculate experimental period laying rate etc., calculating each group of test laying hen egg every day on average heavy, abnormal-shape egg rate, soft shell check rate etc. simultaneously.
Result is shown in table 21.
Table 21 Chinese medicine is on the impact of test chicken laying rate and Egg Quality
Note: result of the test is divided into 1 ~ 7d, 8 ~ 14d, two experimental stages are added up.
Result of the test shows, and test group laying hen is adding up the stage through treatment by Chinese herbs 7d as one, and after drug withdrawal, 8 ~ 14 d are re-used as second statistics stage, and detailed results is in table 12.Statistical result showed, 1st, 2 test group laying hens at the egg productive rate in 8 ~ 14 d stages all apparently higher than 1st ~ 7d, egg is on average heavy also a little more than 1st ~ 7 d simultaneously, and the soft shell shell-breaking rate of egg and abnormal rate are all lower than the 1st ~ 7 d, comparative test result shows, and the 1st group of (the loose treatment group of lotus perfume) resultant effect is better than the 2nd group (four taste Herba Andrographis fall apart).
Result of the test shows, salpingitis type colibacillosis natural occurrence laying hen is observing 14d through treatment by Chinese herbs 7d, the laying rate of test chicken has obvious rising, and Egg Quality also makes moderate progress, and shows that two Chinese powder medicines all have treatment and the effect improving hens salpingitis disease.
5, this clinical expanding test place is selected in the raw Jiang Danjiyangzhichang of original breeding layer chicken company limited of Yunfu, Guangdong Province Luoding City, because Yunfu, Guangdong Province Luoding City is located in more hot place, South China of China, day-light saving time is long, especially the bacterial disease that annual 6 ~ JIUYUE (particularly 7 ~ August) often occurs at feeding process, the benefit that the hens salpingitis disease particularly caused by escherichia coli affects cultivation for a long time always improves.
This test is selected in July, 2014 to August, belongs to the hens salpingitis disease period occurred frequently that being caused by escherichia coli appears in breeding layer chicken field in one-year age.In this test, by morbidity laying hen clinical symptoms, typically analyse pathological change and the method such as bacteria distribution cultivation and qualification, filter out 100 hens salpingitis disease natural occurrence laying hens caused by escherichia coli, and be divided into 2 groups at random, the 1st group (lotus perfume is loose) often organizes 50 test chickens with the 2nd group (four taste Herba Andrographis fall apart).By Drug therapy 7d, and observe 14d, paper examines index comprises: the performance of laying hen clinical symptoms, mortality rate, cure rate and effective percentage, and the index such as the laying rate of test chicken, Egg Quality.
Result of the test shows, salpingitis type colibacillosis natural occurrence laying hen is at, four taste Herba Andrographis loose treatment 7d loose through Chinese medicine lotus perfume respectively and observe 14d, along with the prolongation for the treatment of by Chinese herbs time, natural occurrence test laying hen spirit is recovered gradually, symptom of having loose bowels constantly alleviates, drink for increasing, death stops gradually, laying rate improves constantly, Egg Quality makes moderate progress, and all have about 50% laying hen to be cured in the off-test time, comprehensive evaluation result shows, and the loose four taste Herba Andrographis that are better than of Chinese medicine lotus perfume fall apart.
In sum, this result of the test shows, in South Chinas such as Yunfus, in laying hens essential ration, add that lotus perfume is loose, four taste Herba Andrographis all have the clinical symptoms improving hens salpingitis disease (being caused by escherichia coli), reduce laying hen mortality rate, improve laying rate of laying hen and improve egg quality, promoting the resistance to mistake of disease chicken and gradually recover one's health and reach criterion of cure, comprehensive evaluation result shows, and the loose four taste Herba Andrographis that are better than of Chinese medicine lotus perfume fall apart.
In addition, target animals safety test, experimental clinical trial and expansion clinical trial all result show, in basal diet, adding tested medicine lotus perfume loose, is safe and effective for preventing and treating chicken colibacillosis.Quantity is recommended to be add the tested medicine lotus perfume of 1000 g in every 100 kg diet to fall apart, continuous use 7 d.
comparative example
1, the loose prescription of lotus perfume is selected
(1) test according to the method for embodiment 4, the prescription loose to lotus perfume is selected:
Contrast groups 1: Herba Andrographis.
Contrast groups 2: Herba Andrographis, Herba Diclipterae Chinensis.
(2) detect according to the index of embodiment 4, Comparative result shows, and contrast groups 1 and 2 all has the colibacillary effect of certain suppression, can have certain therapeutic effect to escherichia coli type peritonitis mice; But compared with formula of the present invention (: Herba Andrographis 16.7%, Rhizoma Atractylodis 25%, the Radix Aucklandiae 16.7%, Cortex Magnoliae Officinalis 16.6%, Rhizoma Zingiberis 25%), the formula of contrast groups 1 and 2 to the preventive effect of escherichia coli type peritonitis significantly lower than formula of the present invention.
And the formula of contrast groups 1 and 2 does not have obvious curative effect to the diarrhoea that Oleum Ricini and Folium Sennae cause, and does not significantly advance the effect of mice intestinal function yet.In real work, chicken colibacillosis and treatment time by being permitted multifactorial impact, be not that simple suppression escherichia coli just can perfect realization.Therefore, consider each conditions, formula of the present invention (: Herba Andrographis 16.7%, Rhizoma Atractylodis 25%, the Radix Aucklandiae 16.7%, Cortex Magnoliae Officinalis 16.6%, Rhizoma Zingiberis 25%) be the Chinese medicine formula for the treatment of colibacillosis the best.
2, the loose prescription proportioning of lotus perfume is selected
Test according to the method for embodiment 4 and index, the proportioning of the loose prescription of lotus perfume is optimized, contrast through experimental result, consider each side factor, when the percentage composition of each component is following proportioning in herbal medicine compound preparation of the present invention: 5 ~ 55% Herba Andrographis, 10 ~ 65% Rhizoma Atractylodis, 5 ~ 55% Radix Aucklandiae, 5 ~ 55% Cortex Magnoliae Officinalis, 10 ~ 65 % Rhizoma Zingiberiss, the effect of control chicken colibacillosis preferably can be reached.And optimum proportioning is: Herba Andrographis 16.7%, Rhizoma Atractylodis 25%, the Radix Aucklandiae 16.7%, Cortex Magnoliae Officinalis 16.6%, Rhizoma Zingiberis 25%, and medication optimal dose is 1%.
3, the investigation of the loose area of application of lotus perfume
During in order to investigate practical application, the regional suitability that lotus perfume of the present invention is loose, we also have also been made clinical research experiment in chicken farm, Henan area, concrete grammar is with embodiment 6.
Investigation result shows, and with embodiment 6 compared with the application result of chicken farm, Luoding City, when this chicken farm application in Henan, the loose therapeutic effect for chicken colibacillosis of lotus perfume has obvious reduction, and we analyze this may be because the difference of north-south climate causes.
But with above-mentioned contrast groups 1(Herba Andrographis) with contrast groups 2(Herba Andrographis, Herba Diclipterae Chinensis) curative effect compare, when this chicken farm application in Henan, the loose therapeutic effect for chicken colibacillosis of lotus perfume still has certain advantage.Therefore, in general, lotus perfume of the present invention is loose has significant curative effect for chicken colibacillosis, is particularly useful for the subtropical climate areas such as our southern area.
Claims (9)
1. treat the application of herbal medicine compound preparation in the medicine of preparation treatment chicken colibacillosis of chicken colibacillosis for one kind, it is characterized in that, described herbal medicine compound preparation is made up of the component of following percentage composition: 5 ~ 55% Herba Andrographis, 10 ~ 65% Rhizoma Atractylodis, 5 ~ 55% Radix Aucklandiae, 5 ~ 55% Cortex Magnoliae Officinalis, 10 ~ 65 % Rhizoma Zingiberiss.
2. applying according to claim 1, it is characterized in that, is the application in the medicine of preparation treatment subtropical climate area chicken colibacillosis.
3. apply according to claim 2, it is characterized in that, described subtropical climate area refers to South China of China.
4. treat the application of herbal medicine compound preparation in the medicine of preparation treatment chicken diarrhea of chicken colibacillosis described in claim 1, it is characterized in that, described chicken diarrhea is the diarrhoea caused by Oleum Ricini or Folium Sennae.
5. described in claim 1, treat the application of herbal medicine compound preparation in preparation suppression chicken or mice Intestinal pushing function medicament of chicken colibacillosis.
6. apply according to claim 1, it is characterized in that, the herbal medicine compound preparation of described treatment chicken colibacillosis is made up of the component of following percentage composition: 10 ~ 40% Herba Andrographis, 15 ~ 55% Rhizoma Atractylodis, 10 ~ 40% Radix Aucklandiae, 10 ~ 40% Cortex Magnoliae Officinalis, 15 ~ 55% Rhizoma Zingiberiss.
7. apply according to claim 1, it is characterized in that, the herbal medicine compound preparation of described treatment chicken colibacillosis is made up of the component of following percentage composition: 10 ~ 25% Herba Andrographis, 20 ~ 35% Rhizoma Atractylodis, 10 ~ 25% Radix Aucklandiae, 1 ~ 25% Cortex Magnoliae Officinalis, 20 ~ 35% Rhizoma Zingiberiss.
8. apply according to claim 1, it is characterized in that, the herbal medicine compound preparation of described treatment chicken colibacillosis is made up of the component of following percentage composition: Herba Andrographis 16.7%, Rhizoma Atractylodis 25%, the Radix Aucklandiae 16.7%, Cortex Magnoliae Officinalis 16.6%, Rhizoma Zingiberis 25%.
9. apply according to claim 1, it is characterized in that, the dosage form of the herbal medicine compound preparation of described treatment chicken colibacillosis is powder, preparation technology is as follows: after five kinds of Chinese crude drugs are broken into coarse granule respectively, in the mixing of prescription ratio, further fine powder is broken, crosses 30 mesh sieves, put in V-Mixer and mix 30 minutes, subpackage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510124327.4A CN104784657B (en) | 2015-03-20 | 2015-03-20 | A kind of application of herbal medicine compound preparation in treating chicken colibacillosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510124327.4A CN104784657B (en) | 2015-03-20 | 2015-03-20 | A kind of application of herbal medicine compound preparation in treating chicken colibacillosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104784657A true CN104784657A (en) | 2015-07-22 |
CN104784657B CN104784657B (en) | 2018-08-17 |
Family
ID=53550143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510124327.4A Expired - Fee Related CN104784657B (en) | 2015-03-20 | 2015-03-20 | A kind of application of herbal medicine compound preparation in treating chicken colibacillosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104784657B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109939211A (en) * | 2019-04-25 | 2019-06-28 | 青岛农业大学 | The Chinese veterinary drug preparation and preparation method thereof for treating chicken colibacillosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005132788A (en) * | 2003-10-31 | 2005-05-26 | Lion Corp | Orally disintegrable tablet |
CN102671168A (en) * | 2012-05-07 | 2012-09-19 | 成都绿迪科技有限公司 | Traditional Chinese medicine composition for treating bacillary dysentery |
-
2015
- 2015-03-20 CN CN201510124327.4A patent/CN104784657B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005132788A (en) * | 2003-10-31 | 2005-05-26 | Lion Corp | Orally disintegrable tablet |
CN102671168A (en) * | 2012-05-07 | 2012-09-19 | 成都绿迪科技有限公司 | Traditional Chinese medicine composition for treating bacillary dysentery |
Non-Patent Citations (1)
Title |
---|
汪芳等: "HPLC法同时测定加味穿心莲散中6种成分", 《中成药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109939211A (en) * | 2019-04-25 | 2019-06-28 | 青岛农业大学 | The Chinese veterinary drug preparation and preparation method thereof for treating chicken colibacillosis |
CN109939211B (en) * | 2019-04-25 | 2021-06-01 | 青岛农业大学 | Traditional Chinese veterinary medicine preparation for treating chicken colibacillosis and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104784657B (en) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103689296B (en) | Feed for ewe at later pregnancy and lactation period and preparation method thereof | |
CN104887890A (en) | Medicine composition for treating white scour of chicken and preparation method thereof | |
CN102846864B (en) | Chinese herbal veterinary medicine for preventing and treating swine infectious atrophic rhinitis and preparation process thereof | |
CN104366123A (en) | Functional feed for preventing infectious pancreatic diseases in rainbow trouts and production method thereof | |
CN104258139A (en) | Pharmaceutical composition for preventing and treating chronic swine plague and preparation method of pharmaceutical composition | |
CN103494927B (en) | Traditional Chinese medicine composition for treating chicken respiratory disease and preparation method thereof | |
CN103356767B (en) | Medicinal composition for treating bacterial diarrhea of livestock as well as preparation method and application thereof | |
CN104256165A (en) | Functional feed for preventing and treating chronic swine plague and preparation method of functional feed | |
CN105056159A (en) | Medicine for treating parasitic diseases of pigs and preparation method thereof | |
CN102188494B (en) | Medicament for treating high fever of pigs with pure Chinese medicine | |
CN106389562A (en) | Pudilan Xiaoyan granules, preparation method thereof, and product quality control method | |
CN103652490B (en) | Pig feed for treating blue-eared pig disease and preparation method thereof | |
CN107019739A (en) | Blue oral liquid of a kind of cordate houttuynia a kind of reed mentioned in ancient books and preparation method thereof and product quality control method | |
CN105749154A (en) | Probiotic fermented traditional Chinese medicine compound composition for treating liver cancer and preparation and detection methods thereof | |
CN104784657B (en) | A kind of application of herbal medicine compound preparation in treating chicken colibacillosis | |
CN104474021A (en) | Traditional Chinese medicine composition for treatment of exterior heat and preparation method thereof | |
CN104547186A (en) | Compound fermented type traditional Chinese medicine for preventing and treating fowl cholera and preparation method of compound fermented type traditional Chinese medicine | |
CN104623068B (en) | Treat medicine of fever in children infantile convulsion and preparation method thereof | |
CN103977058B (en) | A kind of Chinese herbal medicament oral liquid and production technology of preventing and treating chicken colibacillosis | |
CN109432287B (en) | Traditional Chinese medicine oral liquid for preventing and treating excessive heat syndrome of poultry qi system and preparation method thereof | |
CN103417653B (en) | Veterinary-use compound pure Chinese herbal medicine for treating coccidium and preparation method of oral liquid of same | |
CN111588801A (en) | Traditional Chinese medicine dispersible granule for preventing livestock and poultry epidemic diseases and preparation method thereof | |
CN104352582A (en) | Medicine for preventing and treating colibacillosis of chickens and preparation method thereof | |
CN103690771B (en) | Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof | |
CN101554420A (en) | Radix scutellariae and humifuse euphorbia herb powder and preparation technology and quality control method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180817 |